This inventor holds 1 USPTO granted patent. Top assignee: Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu. Active years: 1988.
Company Filing History:
Years Active: 1988
Title: Marta Beitova: Innovator in Antineoplastic Compounds
Introduction
Marta Beitova is a distinguished inventor based in Prague, Czech Republic. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds with antineoplastic properties. Her innovative work has the potential to impact the treatment of malignant neoplastic diseases in mammals.
Latest Patents
Marta Beitova holds a patent for a compound known as 6-purinyl N-/2-chloroethyl/carbamate and thiocarbamate. This patent describes a process for synthesizing these compounds, which are derived from purine derivatives such as hypoxanthine or 6-mercaptopurine. The compounds exhibit remarkable antineoplastic effects both in vitro and in vivo, showcasing their potential for therapeutic applications.
Career Highlights
Throughout her career, Marta has focused on the intersection of chemistry and medicine. Her work at Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu has allowed her to collaborate with other experts in the field. She has been instrumental in advancing research that aims to improve treatment options for cancer patients.
Collaborations
Marta Beitova has worked alongside notable colleagues such as Antonin Cerny and Jiri Krepelka. Their collaborative efforts have contributed to the successful development of innovative compounds that hold promise for future medical applications.
Conclusion
Marta Beitova's contributions to the field of medicinal chemistry, particularly through her patent on antineoplastic compounds, highlight her role as a key innovator. Her work continues to pave the way for advancements in cancer treatment.